Home›Compare›MangoRx vs Mochi Health

MangoRx vs Mochi Health: Which Is Better?

Head-to-head comparison of MangoRx and Mochi Health based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Mochi Health scores higher overall in our independent evaluation (66.8/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx
67

Physician-founded telehealth platform offering flat-rate compounded GLP-1 medications with dietitian support, expanding into 15+ specialty care categories.

Visit Mochi Health

Score Breakdown

DimensionMangoRxMochi Health
Overall Score58/10066.8/100 ✓
Trust & Safety30%55/10065/100 ✓
Value25%62/10075/100 ✓
Experience20%58/10060/100 ✓
Product Range15%66/10070/100 ✓
Reputation10%45/10060/100 ✓

At a Glance

Founded20212022
HeadquartersDallas, TXSan Francisco, CA
Publicly tradedYes (MGRX)No
Treatment categories56
Treatments listed53
Starting price$50/mo$49/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryMangoRxMochi Health
Men's Health——
Sexual Health$59–$75
Mango ED (sildenafil or tadalafil)
—
Weight Loss / GLP-1$299
Slim (compounded oral semaglutide ODT)
$49–$69
Wellness Plus (Insurance Plan)

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Mochi Health

+Flat-rate compounded GLP-1 pricing: $60/mo semaglutide and $90/mo tirzepatide at ALL doses, plus a $79/mo membership
+Comprehensive care model: physician + dietitian + 24/7 support, not just a prescription mill
+Multiple medication forms: injectable, oral tablet, oral drop, and microdose semaglutide
−Eli Lilly lawsuit over alleged deceptive tirzepatide marketing — litigation ongoing as of early 2026
−BBB complaints about billing, cancellation, and confusing refund windows (24-hour vs 72-hour policy)
−No Medicaid, Medicare, or TRICARE accepted — excludes significant patient populations
Read the full Mochi Health review →

MangoRx vs Mochi Health — FAQ

Is MangoRx better than Mochi Health?

▾

Mochi Health scores higher overall in our independent evaluation (66.8/100 vs 58/100), leading on trust & safety, value, experience, product range, reputation.

Is MangoRx or Mochi Health cheaper?

▾

Mochi Health has the lower starting price (from $49/mo vs $50/mo for MangoRx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do MangoRx and Mochi Health both offer?

▾

Both platforms treat Men's Health, Sexual Health, Weight Loss / GLP-1. MangoRx covers 5 treatment categories total and Mochi Health covers 6.

Still deciding?

MangoRx alternativesMochi Health alternativesTake the Match Quiz